PD Dr. med. Cyrus Khandanpour, MBA Medizinische Klinik A Universitätsklinikum Münster
Acute myeloid leukemia is a malignant disease of the hematopoietic system with a poor prognosis. Current therapy consists of chemoth erapy and allogeneic bone marrow transplantation. We are looking for new therapeutic approaches to improve prognosis AML by targeting genetic and epigenetic changes in the leukemic cells as well as in the surrounding stroma.